相似文献
1
Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics.
Clin Pharmacol Ther. 2009 Apr;85(4):434-8. doi: 10.1038/clpt.2008.302. Epub 2009 Feb 11.
2
Modulation of drug metabolism in infectious and inflammatory diseases.
Drug Metab Rev. 1999 Feb;31(1):29-41. doi: 10.1081/dmr-100101906.
3
Understanding cooperativity in human p450 mediated drug-drug interactions.
Drug Metab Rev. 2007;39(2-3):567-79. doi: 10.1080/03602530701498521.
4
Regulation of cytochrome p450 by inflammatory mediators: why and how?
Drug Metab Dispos. 2001 Mar;29(3):207-12.
5
Drug metabolism and drug interactions in the elderly.
Best Pract Res Clin Gastroenterol. 2001 Dec;15(6):897-918. doi: 10.1053/bega.2001.0249.
6
Cytochrome P450 regulation and drug biotransformation during inflammation and infection.
Curr Drug Metab. 2004 Jun;5(3):235-43. doi: 10.2174/1389200043335559.
7
Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics.
Genes (Basel). 2020 Dec 16;11(12):1509. doi: 10.3390/genes11121509.
8
Cytochrome P450: drug metabolism--why it's so important to understand.
Geriatr Nurs. 2010 Sep-Oct;31(5):385-7. doi: 10.1016/j.gerinurse.2010.08.007.
9
[Our cytochrome P450: a waste-disposal enterprise much in demand].
Anaesthesist. 2002 Jan;51(1):1. doi: 10.1007/s101-002-8364-8.
10
Characterization of human cytochrome P450 enzymes.
FASEB J. 1992 Jan 6;6(2):745-8. doi: 10.1096/fasebj.6.2.1537465.
引用本文的文献
1
Effect of Meloxicam on the Pharmacokinetics of Cefquinome in Endotoxemic Sheep.
Vet Med Sci. 2025 Sep;11(5):e70462. doi: 10.1002/vms3.70462.
2
Polychlorinated biphenyls (PCBs) interact with drug metabolism in vivo.
Arch Toxicol. 2025 Aug 15. doi: 10.1007/s00204-025-04145-6.
3
Pharmacotherapy variability and precision medicine in neurocritical care.
Front Neurol. 2025 Jul 18;16:1630163. doi: 10.3389/fneur.2025.1630163. eCollection 2025.
4
A transcriptomic landscape analysis of human necrotizing enterocolitis: Important roles of immune infiltration.
Pediatr Discov. 2023 Jun 9;1(1):e1. doi: 10.1002/pdi3.1. eCollection 2023 Jun.
5
Identifying factors related to sertraline concentrations in child/adolescent and adult patients: insights from a therapeutic drug monitoring service.
BMC Psychiatry. 2025 Jun 6;25(1):590. doi: 10.1186/s12888-025-07033-6.
6
The Immature Infant Liver: Cytochrome P450 Enzymes and their Relevance to Vaccine Safety and SIDS Research.
Int J Med Sci. 2025 Apr 28;22(10):2434-2445. doi: 10.7150/ijms.114402. eCollection 2025.
7
Safety Profile, Toxicokinetic, and Intestinal Absorption Differences of a Naturally-Derived Anti-Rheumatic Drug, Sinomenine Hydrochloride, in Normal and Arthritic Rats.
Pharmaceutics. 2025 Apr 7;17(4):484. doi: 10.3390/pharmaceutics17040484.
8
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation.
J Xenobiot. 2025 Mar 14;15(2):44. doi: 10.3390/jox15020044.
9
Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption.
Br J Clin Pharmacol. 2025 Jul;91(7):2028-2044. doi: 10.1002/bcp.70019. Epub 2025 Mar 4.
10
Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19.
Medicina (Kaunas). 2025 Feb 8;61(2):298. doi: 10.3390/medicina61020298.
本文引用的文献
1
TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease.
Biochem Pharmacol. 2009 Feb 1;77(3):464-71. doi: 10.1016/j.bcp.2008.10.029. Epub 2008 Nov 6.
2
Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium.
Drug Metab Dispos. 2009 Feb;37(2):366-74. doi: 10.1124/dmd.108.024240. Epub 2008 Oct 29.
3
Cytochrome P450 2C9 mediated metabolism in people with and without cancer.
Int J Clin Pharmacol Ther. 2008 Jul;46(7):365-74. doi: 10.5414/cpp46365.
4
Origin and physiological roles of inflammation.
Nature. 2008 Jul 24;454(7203):428-35. doi: 10.1038/nature07201.
5
Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.
Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):137-49. doi: 10.1517/17425255.4.2.137.
6
Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer.
Drug Metab Dispos. 2008 Feb;36(2):205-16. doi: 10.1124/dmd.107.018747.
7
Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.
Free Radic Biol Med. 2008 Mar 15;44(6):1161-8. doi: 10.1016/j.freeradbiomed.2007.12.010. Epub 2007 Dec 23.
8
Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins.
J Biol Chem. 2008 Jan 11;283(2):889-98. doi: 10.1074/jbc.M708821200. Epub 2007 Nov 9.
9
Drug interaction studies of therapeutic proteins or monoclonal antibodies.
J Clin Pharmacol. 2007 Dec;47(12):1540-54. doi: 10.1177/0091270007308616. Epub 2007 Oct 25.
10
Genetics and genomics of hepatic acute phase reactants: a mini-review.
Inflamm Allergy Drug Targets. 2007 Jun;6(2):109-15. doi: 10.2174/187152807780832247.
Zotero 插件